Analysed CMS (8A8:SGX) News Sources
AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations in central nervous system and autoimmune diseases
10-02-2026
yahoo.com
A Look At China Medical System Holdings (SEHK:867) Valuation After New AI Drug Partnership And Trial Approval
15-02-2026
yahoo.com
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
24-02-2026
yahoo.com
CMS(867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity
05-03-2026
yahoo.com
CMS(867.HK/8A8.SG):Ruxolitinib Phosphate Cream (Lumirix®) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
13-03-2026
yahoo.com
CMS(867.HK/8A8.SG): New Drug for Renal Anaemia Desidustat Tablets Approved in China
13-03-2026
yahoo.com
CMS (867.HK; 8A8.SG): NDA for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China
23-04-2026
yahoo.com
CMS (867.HK/8A8.SG) Signed An Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer® and Cosmofer®
27-04-2026
yahoo.com
What is the current price of CMS (8A8:SGX)?
The current price of CMS (8A8:SGX) is $1.83.
CMS (8A8:SGX) absolute price change since previous trading day?
The absolute price change of CMS (8A8:SGX) since the previous trading day is $0.13.
CMS (8A8:SGX) percentage price change since previous trading day?
The percentage price change of CMS (8A8:SGX) since the previous trading day is 7.647%.
What is the most recent average sentiment score for CMS (8A8:SGX)?
The most recent average sentiment score for CMS (8A8:SGX) is 60 out of 100.
What is the most recent average sentiment for CMS (8A8:SGX)?
The most recent sentiment for CMS (8A8:SGX) is .
SEC-8K** Filing Unavailable For CMS (8A8:SGX)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.